LRN Report: Ethics and Compliance Practices Converging Amid the ‘Long Arm’ Global Impact of US Regulation
New Global Standards Editon of Flagship Report Analyzes Four Years of Global Data to Pinpoint…
3 years ago
Wemade Applies Extensive Skill Balance Update for MIR4
Combat skill adjustments for all classes - Warrior, Lancer, Sorcerer, Taoist, Arbalist, Darkist Magic Square…
3 years ago
NTT Announces Research Applying Genetic Data to Improve Athletic Performance and Health
To provide athletes tools for training, practice and game analysis based on NTT’s IoT, AI…
3 years ago
Hurricane Electric Expands Global Network in The Philippines With New Point of Presence at ePLDT VITRO Makati 1 in Manila
Latest Point of Presence in the Philippines brings high-speed connectivity to this rapidly growing digital…
3 years ago
Alibaba Pictures announces to acquire Damai and transition into the flagship offline entertainment platform of the Alibaba Digital Media and Entertainment Group
HONG KONG SAR - Media OutReach - 19 September 2023 - Alibaba Pictures Group Limited…
3 years ago
FANUC Announces Production of its One Millionth Robot
Landmark achievement strengthens FANUC’s position as a global automation leader. ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--#EV--FANUC CORPORATION,…
3 years ago
K-Wonderland Connects with Korean Artists Gen Z Loves
Metaverse fan party with universal entertainers Lee Eun-ji, THE BOYZ, and Just Jerk K-Wonderland, a…
3 years ago
BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®
European Commission approves TEVIMBRA for previously treated advanced or metastatic esophageal squamous cell carcinoma (ESCC)…
3 years ago
Drug Farm Doses First Patient in Phase 1 Trial for ALPK1 Inhibitor, DF-003
First-in-human trial for DF-003, the 2nd compound from IDInVivo and MedChem5 platform to enter clinical…
3 years ago
BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA® (tislelizumab)
Regulatory marketing applications for U.S. and EU under review, with plans to expand TEVIMBRA commercial…
3 years ago